Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daschle’s Prescription for FDA: Leadership, Policy, Money, and Coordination

Executive Summary

Restoring confidence in FDA "as the leading science-based regulatory agency in the world" will be a priority for the Department of Health and Human Services, Secretary nominee Tom Daschle told the Senate Health, Education, Labor and Pensions Committee Jan. 8

You may also be interested in...



HHS Secretary-Nominee Sebelius Hearings Set Before Senate Health, Finance Committees

Rapid succession of hearings (March 31 and April 2) suggests smooth path to confirmation.

FDA Should Embrace Its E-Future, Industry Reps Say

To the next FDA commissioner: your agency needs to move into the 21st century now and it can start by accepting digital drug submissions

FDA Should Embrace Its E-Future, Industry Reps Say

To the next FDA commissioner: your agency needs to move into the 21st century now and it can start by accepting digital drug submissions

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel